Hugo Rupert Alexander Fry

Acambis Research Ltd. was founded in 1992 and engages in research and experimental development on natural sciences and engineering. The joint venture company is based in Reading, UK.

Part of Sanofi, RPR (US) Ltd. functions as an investment holding British company. The company is based in Guildford, UK.

Part of Sanofi, Aventis Pharma Ltd. is a British company that engages in the wholesale of pharmaceutical goods. The company is based in Reading, UK. Aventis Pharma was founded in 1980.

Part of Sanofi, Aventis Pharma Holdings Ltd. functions as an investment holding British company. The company is based in Guildford, UK. Aventis Pharma Holdings was founded in 1999.

Rhone-Poulenc Rorer Ltd. engages in the research, production and distribution of pharmaceutical products. The company is headquartered in Guildford, the United Kingdom.

Fisons Ltd. manufactures pharmaceutical preparations. The company is headquartered in Guildford, the United Kingdom.

Founded in 1994, Hoechst Marion Roussel Ltd. (United Kingdom) is a British pharmaceutical company that manufactures pharmaceutical products. Part of Sanofi, the company is based in Guildford, UK.

May & Baker Ltd. manufactures pharmaceutical products. The company is headquartered in Guildford, GB.

Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA.

Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA.

Topas Therapeutics GmbH engages in pharmaceutical preparations. The company is headquartered in Hamburg, Germany.

Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA.